| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |